← Back to Search
Survivorship Care Coordination for Prostate Cancer
Mount Vernon, IL
N/A
Waitlist Available
Led By Ronald C Chen
Research Sponsored by NRG Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The ADT must be planned for at least 4 months and must include luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist
The participant must be able to complete required questionnaires in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and 24 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether increasing the coordination of care between the cancer care team and the primary care team improves care and outcomes for prostate cancer survivors.
See full description
Who is the study for?
This trial is for prostate cancer survivors who are undergoing radiation and androgen deprivation therapy. They must be able to fill out questionnaires in English, have a primary care provider or cardiologist, and consent to the study. Practices need IRB approval, complete specific training, and follow certain protocols. Patients already on ADT for no more than 120 days may join.Check my eligibility
What is being tested?
The trial tests if increasing survivorship care planning can improve outcomes for prostate cancer survivors on therapy that raises risks of diabetes and heart issues. It compares standard care with an increased dose of coordinated survivorship care between oncologists and primary caregivers.See study design
What are the potential side effects?
Since this trial focuses on survivorship care planning rather than a medical intervention, there are no direct side effects from treatments like drugs or surgery being studied.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for hormone therapy for my cancer for at least 4 months.
show original
Select...
I can complete questionnaires in English.
show original
Select...
I have prostate cancer and will be treated with radiation and hormone therapy aiming for a cure.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline and 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and 24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of patients who saw a primary care provider (PCP) or cardiologist and had fasting blood glucose and cholesterol checked
Secondary study objectives
Calculated cardiovascular (CVD) risk score
Coordination of care with respect to the PCP or cardiologist
Current practice related to SCP delivery and prostate cancer survivor monitoring
+3 moreOther study objectives
Coordination of care with respect to the cancer specialist
Satisfaction of care with respect to the cancer specialist
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm B (enhanced SCP)Experimental Treatment3 Interventions
Practices review a treatment plan with patient and send it to the PCP at the beginning of RT. Practices also review a SCP as arm A.
Group II: Arm A (standard)Active Control2 Interventions
Practices review a SCP with patients and send it to the PCP during the last week of RT.
Find a Location
Closest Location:SSM Health Good Samaritan· Mount Vernon, IL
Who is running the clinical trial?
NRG OncologyLead Sponsor
241 Previous Clinical Trials
104,441 Total Patients Enrolled
National Cancer Institute (NCI)NIH
14,057 Previous Clinical Trials
41,148,882 Total Patients Enrolled
Ronald C ChenPrincipal InvestigatorNRG Oncology
1 Previous Clinical Trials
586 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am scheduled for hormone therapy for my cancer for at least 4 months.I can complete questionnaires in English.My practice can deliver Survivorship Care Plans (SCPs) to prostate cancer patients using the study's template.I have prostate cancer and will be treated with radiation and hormone therapy aiming for a cure.My healthcare provider is part of a study comparing usual care with a new approach.I started hormone therapy for cancer less than 120 days ago.
Research Study Groups:
This trial has the following groups:- Group 1: Arm A (standard)
- Group 2: Arm B (enhanced SCP)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.